| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |